Phototherapy and photochemotherapy for polymorphic light eruption desensitisation: a five year case series review from a university teaching hospital

A. Aslam, L. Fullerton, S. H. Ibbotson (Lead / Corresponding author)

Research output: Contribution to journalLetterpeer-review

6 Citations (Scopus)
125 Downloads (Pure)

Abstract

Polymorphic light eruption (PLE) is the most common immunological photodermatosis, with a prevalence of 18% in Europe1. The pathogenesis of PLE appears to involve delayed cell mediated hypersensitivity and aberrant Langerhans cell function2,3. Phototherapy, using narrowband UVB (UVB) or psoralen-ultraviolet A (PUVA) photochemotherapy, is widely used for prophylactic desensitisation in PLE, with benefit experienced in 90% of patients4,5
Original languageEnglish
Pages (from-to)225-227
Number of pages3
JournalPhotodermatology, Photoimmunology & Photomedicine
Volume33
Issue number4
Early online date17 Apr 2017
DOIs
Publication statusPublished - 11 May 2017

Keywords

  • Phototherapy
  • Polymorphic light eruption
  • Desensitisation
  • UVB

Fingerprint Dive into the research topics of 'Phototherapy and photochemotherapy for polymorphic light eruption desensitisation: a five year case series review from a university teaching hospital'. Together they form a unique fingerprint.

Cite this